云南白药
(000538)
| 流通市值：911.51亿 | | | 总市值：911.58亿 |
| 流通股本：17.84亿 | | | 总股本：17.84亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 21,884,075,971.15 | 11,602,596,895.18 | 41,186,999,090.31 | 30,654,214,209.01 |
| 营业总成本 | 18,422,708,603.11 | 9,475,409,648 | 36,210,224,002.36 | 26,074,760,939.86 |
| 其他经营收益 | | | | |
| 营业利润 | 4,274,084,089.7 | 2,361,585,348.27 | 6,038,895,380.87 | 5,605,052,816.15 |
| 利润总额 | 4,282,557,064.82 | 2,360,878,953.35 | 6,043,270,703.73 | 5,615,098,543.69 |
| 净利润 | 3,697,247,984.17 | 2,030,581,204.88 | 5,189,940,856.98 | 4,789,170,075.42 |
| 每股收益 | | | | |
| 其他综合收益 | -15,517,150.66 | -8,785,384.58 | -6,013,856.89 | 3,052,405.37 |
| 综合收益总额 | 3,681,730,833.51 | 2,021,795,820.3 | 5,183,927,000.09 | 4,792,222,480.79 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 34,268,165,040.11 | 35,920,532,583.79 | 34,034,592,773.13 | 33,776,781,451.64 |
| 非流动资产: | | | | |
| 非流动资产合计 | 20,877,104,609.36 | 20,536,695,893.88 | 20,233,988,358.69 | 19,566,703,269.75 |
| 资产总计 | 55,145,269,649.47 | 56,457,228,477.67 | 54,268,581,131.82 | 53,343,484,721.39 |
| 流动负债: | | | | |
| 流动负债合计 | 12,985,969,362.11 | 13,099,488,721.81 | 12,890,249,055.55 | 12,366,323,961.71 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,111,330,480.09 | 1,188,096,336.82 | 1,230,831,247.92 | 1,159,287,149.07 |
| 负债合计 | 14,097,299,842.2 | 14,287,585,058.63 | 14,121,080,303.47 | 13,525,611,110.78 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 40,973,152,783.1 | 42,096,489,419.57 | 40,044,058,844.44 | 39,733,402,690.02 |
| 股东权益合计 | 41,047,969,807.27 | 42,169,643,419.04 | 40,147,500,828.35 | 39,817,873,610.61 |
| 负债和股东权益合计 | 55,145,269,649.47 | 56,457,228,477.67 | 54,268,581,131.82 | 53,343,484,721.39 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 25,288,733,028.81 | 11,534,880,893.58 | 46,289,764,400.58 | 34,692,435,604.9 |
| 经营活动现金流出小计 | 21,182,693,660.48 | 10,705,864,774.24 | 41,690,070,520.14 | 30,236,466,093.36 |
| 经营活动产生的现金流量净额 | 4,106,039,368.33 | 829,016,119.34 | 4,599,693,880.44 | 4,455,969,511.54 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 4,641,320,606.38 | 2,144,697,631.32 | 7,941,923,117.94 | 4,868,926,894.34 |
| 投资活动现金流出小计 | 5,226,006,150.52 | 2,672,108,464.95 | 9,927,260,178.74 | 7,082,314,175.11 |
| 投资活动产生的现金流量净额 | -584,685,544.14 | -527,410,833.63 | -1,985,337,060.8 | -2,213,387,280.77 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 23,985,516.95 | 5,014,543.13 | 335,611,144.99 | 156,213,144.52 |
| 筹资活动现金流出小计 | 3,066,202,853.55 | 190,716,126.86 | 4,684,602,943.59 | 4,626,307,191.81 |
| 筹资活动产生的现金流量净额 | -3,042,217,336.6 | -185,701,583.73 | -4,348,991,798.6 | -4,470,094,047.29 |
| 汇率变动对现金及现金等价物的影响 | -10,320,105.79 | -5,634,105.73 | -8,661,908.99 | -6,359,311.98 |
| 现金及现金等价物净增加额 | 468,816,381.8 | 110,269,596.25 | -1,743,296,887.95 | -2,233,871,128.5 |
| 期末现金及现金等价物余额 | 9,001,049,069.19 | 8,642,504,264 | 8,532,232,687.39 | 8,041,658,446.84 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 468,816,381.8 | - | -1,743,296,887.95 | - |
最新报告期：2026-09-10| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 兴业证券 | 孙媛媛,董晓洁,黄翰漾 | 3.04 | 3.30 | 3.54 | 2026-09-10 |
| 中信建投 | 刘若飞,沈兴熙,贺菊颖 | 3.13 | 3.36 | 3.62 | 2026-09-06 |
| 中金公司 | 夏璐,张琎,朱言音 | 3.22 | 3.38 | -- | 2026-08-31 |
| 华泰证券 | 代雯,唐庆雷,张云逸 | 3.10 | 3.36 | 3.59 | 2026-08-29 |